Skip to main content
California Medicine logoLink to California Medicine
. 1962 Feb;96(2):86–88.

TREATMENT OF ENDOTOXIC SHOCK—The Dilemma of Vasopressor and Vasodilator Therapy

Max H Weil, Robert B Sudrann, Herbert Shubin
PMCID: PMC1574840  PMID: 14005656

Abstract

Hemodynamic studies have demonstrated that the fall of blood pressure in shock caused by endotoxin in dogs does not result primarily from dilatation or “vasomotor collapse.” Indeed, vasoconstriction is increased and may be excessive. Progression of shock has recently been blamed on such excessive vasoconstriction. For this reason the use of sympathomimetic drugs as vasopressor agents has been challenged and sympatholytic or adrenolytic agents have been recommended.

In the present study, vasopressor and vasodilator drugs were used for the treatment of shock in dogs caused by endotoxin. Vasodilator drugs, when used after the onset of shock, hastened a fatal outcome but vasopressor agents were not detrimental when used in moderate doses.

The effectiveness of the vasopressor agent is not necessarily due to a primary vasoconstrictor action on arteries and arterioles, as previously assumed.

Full text

PDF
86

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. HINSHAW L. B., MACLEAN L. D., SPINK W. W., VISSCHER M. B., WEIL M. H. Hemodynamic effects of vasopressor agent (metaraminol) on hypotension in dogs produced by endotoxin. Proc Soc Exp Biol Med. 1956 Jul;92(3):610–612. doi: 10.3181/00379727-92-22559. [DOI] [PubMed] [Google Scholar]
  2. LILLEHEI R. C., MACLEAN L. D. Physiological approach to successful treatment of endotoxin shock in the experimental animal. AMA Arch Surg. 1959 Mar;78(3):464–471. doi: 10.1001/archsurg.1959.04320030108018. [DOI] [PubMed] [Google Scholar]
  3. LILLEHEI R. C., MACLEAN L. D. The intestinal factor in irreversible endotoxin shock. Ann Surg. 1958 Oct;148(4):513–525. doi: 10.1097/00000658-195810000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. MACLEAN L. D., SPINK W. W., VISSCHER M. B., WEIL M. H. Canine intestinal and liver weight changes induced by E. coli endotoxin. Proc Soc Exp Biol Med. 1956 Jul;92(3):602–605. doi: 10.3181/00379727-92-22557. [DOI] [PubMed] [Google Scholar]
  5. MACLEAN L. D., SPINK W. W., VISSCHER M. B., WEIL M. H. Studies on the circulatory changes in the dog produced by endotoxin from gram-negative microorganisms. J Clin Invest. 1956 Nov;35(11):1191–1198. doi: 10.1172/JCI103373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. MACLEAN L. D., WEIL M. H. Hypotension (shock) in dogs produced by Escherichia coli endotoxin. Circ Res. 1956 Sep;4(5):546–556. doi: 10.1161/01.res.4.5.546. [DOI] [PubMed] [Google Scholar]
  7. WEIL M. H., MILLER B. S. Experimental studies on therapy of circulatory failure produced by endotoxin. J Lab Clin Med. 1961 May;57:683–693. [PubMed] [Google Scholar]
  8. ZWEIFACH B. W., THOMAS L. The relationship between the vascular manifestations of shock produced by endotoxin, trauma, and hemorrhage. I. Certain similarities between the reactions in normal and endotoxin-tolerant rats. J Exp Med. 1957 Sep 1;106(3):385–401. doi: 10.1084/jem.106.3.385. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from California Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES